$3.460
+0.201 (+5.81%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
SONM Prediction & Forecast by Similar Chart Analysis
Alphio's SONM stock price prediction model matches the current DNA X Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.47 (+0.20%). The 1-week path is $3.45 (-0.39%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy DNA X Inc Stock?
Sonim Technologies Inc is a good buy right now due to its recent positive momentum and favorable valuation metrics. The stock has shown a 5-day change of +7.12% and a year-to-date change of +20.14%, suggesting a recovery trend. Additionally, the RSI is at 60.86, indicating that the stock is neither overbought nor oversold, which is a good entry point for long-term investors. However, the main risk is the significant year-over-year decline of -67.58%, which reflects past performance challenges that could impact future growth.
SONM stock price ended at $3.46 on Friday, after rising +5.81%
DNA X Inc (SONM) last closed at $3.46, gaining +5.81%. These facts feed the 1-day and 1-week SONM price prediction above.
Forecast Drivers
DNA X Inc (SONM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches SONM, ranked by similarity.
Seasonality analysis for SONM
Historically the probability of a positive August return for SONM is 31.75%. June offers the highest probability of a positive month at 51.67%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.